alpha-ergocryptine has been researched along with lisuride in 1 studies
Studies (alpha-ergocryptine) | Trials (alpha-ergocryptine) | Recent Studies (post-2010) (alpha-ergocryptine) | Studies (lisuride) | Trials (lisuride) | Recent Studies (post-2010) (lisuride) |
---|---|---|---|---|---|
74 | 1 | 8 | 756 | 80 | 31 |
Protein | Taxonomy | alpha-ergocryptine (IC50) | lisuride (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.02 | |
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.041 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.559 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0003 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.016 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0029 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0005 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0043 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0005 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.173 | |
Histamine H2 receptor | Homo sapiens (human) | 1.04 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.041 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.003 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.02 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0005 | |
Histamine H1 receptor | Homo sapiens (human) | 0.16 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0002 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0051 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boess, FG; Monsma, FJ; Sleight, AJ | 1 |
1 other study(ies) available for alpha-ergocryptine and lisuride
Article | Year |
---|---|
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
Topics: Adenylyl Cyclases; Amino Acid Substitution; Binding Sites; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Ligands; Lysergic Acid Diethylamide; Mutagenesis, Site-Directed; Mutation; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1998 |